• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
Pharmacy Times
Pharmacy Times
Spotlight
Practice PearlsWomen's HealthZoster
Clinical Role
View MoreHospitalOncologyPharmacy TechnicianRetailSpecialty PharmacyStudent
Clinical
View MoreAllergyBrain HealthBreast CancerCardiovascular HealthCoronavirusCough and ColdDiabetesFluHematologyImmunizationInfectious DiseaseNeurologyPain ManagementVitamins and Supplements
News
All News
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Events
Upcoming Events
Upcoming Webinars
CME/CE
Resources
Cou-Co
Educated Patient
Interactive Tools
Partners
Sponsored
Subscribe
  • About Us
  • Advertise
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information

© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.

Spotlight
  • Practice Pearls
  • Women's Health
  • Zoster
Clinical RoleSee All >
  • Hospital
  • Oncology
  • Pharmacy Technician
  • Retail
  • Specialty Pharmacy
  • Student
ClinicalSee All >
  • Allergy
  • Brain Health
  • Breast Cancer
  • Cardiovascular Health
  • Coronavirus
  • Cough and Cold
  • Diabetes
  • Flu
  • Hematology
  • Immunization
  • Infectious Disease
  • Neurology
  • Pain Management
  • Vitamins and Supplements
  • About Us
  • Advertise
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Do Not Sell My Information
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.

Advancements in the Treatment and Management of HER2-Positive Early Breast Cancer

Advancements in Treatment and Management of HER2-Positive Early Breast Cancer: Introduction and the APHINITY Trial

July 24th 2020

Disease-Free Survival and the KATHERINE Study

July 24th 2020

Review of the ExteNET Trial and the TRAIN-2 Trial

July 24th 2020

Agents or Regimens Moving from Metastatic to Early Stage

July 24th 2020

Role of Biosimilars in Breast Cancer

July 24th 2020

Subcutaneous Combination Therapy With the FeDeriCa Study

July 24th 2020

Comparison of IV vs SQ Dosing and Patient Factors

July 24th 2020

Barriers for Novel Agents

July 24th 2020

Pharmacists’ Role for Transitioning from IV to SQ

July 24th 2020

Telehealth During COVID-19 Pandemic

July 24th 2020